409
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Work absenteeism, disability, and lost wages among patients with acute myeloid leukemia and their caregivers: a cohort study using US administrative claims and productivity data

, , , , , , , & ORCID Icon show all
Pages 521-532 | Received 25 Aug 2023, Accepted 19 Jan 2024, Published online: 26 Feb 2024

References

  • U.S. Department of Health and Human Services. SEER cancer stat facts: AML [Internet]. [cited 2023 Dec 7]. Available from: https://seer.cancer.gov/statfacts/html/amyl.html.
  • Smith GL, Lopez-Olivo MA, Advani PG, et al. Financial burdens of cancer treatment: a systematic review of risk factors and outcomes. J Natl Compr Canc Netw. 2019;17(10):1184–1192. doi: 10.6004/jnccn.2019.7305
  • Bentley C, Teckle P, McQuarrie L, et al. Impact of cancer on income, wealth and economic outcomes of adult cancer survivors: a scoping review. BMJ Open. 2022;12(9):e064714. doi: 10.1136/bmjopen-2022-064714
  • Tallman MS, Wang ES, Altman JK, et al. Acute myeloid leukemia, version 3.2019, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2019;17(6):721–749. doi: 10.6004/jnccn.2019.0028
  • Granroth G, Khera N, Arana Yi C. Progress and challenges in survivorship after acute myeloid leukemia in adults. Curr Hematol Malig Rep. 2022;17(6):243–253. doi: 10.1007/s11899-022-00680-6
  • Zeidan AM, Mahmoud D, Kucmin-Bemelmans IT, et al. Economic burden associated with acute myeloid leukemia treatment. Expert Rev Hematol [Internet]. 2016;9:79–89. doi: 10.1586/17474086.2016.1112735
  • Redaelli A, Botteman MF, Stephens JM, et al. Economic burden of acute myeloid leukemia: a literature review. Cancer Treat Rev. 2004;30(3):237–247. doi: 10.1016/j.ctrv.2003.11.002
  • de Boer AGEM, de Wind A, Coenen P, et al. Cancer survivors and adverse work outcomes: associated factors and supportive interventions. Br Med Bull. 2023;145(1):60–71. doi: 10.1093/bmb/ldac028
  • Persoon S, Buffart LM, Chinapaw MJM, et al. Return to work experiences of patients treated with stem cell transplantation for a hematologic malignancy. Support Care Cancer. 2019;27(8):2987–2997. doi: 10.1007/s00520-018-4596-0
  • Earle CC, Chretien Y, Morris C, et al. Employment among survivors of lung cancer and colorectal cancer. J Clin Oncol. 2010;28(10):1700–1705. doi: 10.1200/JCO.2009.24.7411
  • Denzen EM, Thao V, Hahn T, et al. Financial impact of allogeneic hematopoietic cell transplantation on patients and families over 2 years: results from a multicenter pilot study. Bone Marrow Transplant. 2016;51(9):1233–1240. doi: 10.1038/bmt.2016.103
  • Pahlavanzade S, Khosravi N, Moeini M. The effect of a family need-based program on burden of caregivers of leukemia patients in Isfahan in 2013-2014. Iran J Nurs Midwifery Res. 2014;19(6):629–634.
  • Grover S, Rina K, Malhotra P, et al. Caregiver burden in the patients of acute myeloblastic leukemia. Indian J Hematol Blood Transfus An Off J Indian Soc Hematol Blood Transfus. 2019;35(3):437–445. doi: 10.1007/s12288-018-1048-4
  • von Elm E, Altman DG, Egger M, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med. 2007;147(8):573–577. doi: 10.7326/0003-4819-147-8-200710160-00010
  • Paltrinieri S, Vicentini M, Mazzini E, et al. Factors influencing return to work of cancer survivors: a population-based study in Italy. Support Care Cancer. 2020;28(2):701–712. doi: 10.1007/s00520-019-04868-0
  • Eriksson L, Wennman-Larsen A, Bergkvist K, et al. Important factors associated with sick leave after allogeneic haematopoietic stem cell transplantation—a 1-year prospective study. J Cancer Surviv. 2021;15(6):933–941. doi: 10.1007/s11764-020-00986-5
  • Timilshina N, Breunis H, Tomlinson GA, et al. Long-term recovery of quality of life and physical function over three years in adult survivors of acute myeloid leukemia after intensive chemotherapy. Leukemia. 2019;33(1):15–25. doi: 10.1038/s41375-018-0162-5
  • Kurosawa S, Yamaguchi T, Mori A, et al. Incidence and predictors of recurrent sick leave in survivors who returned to work after allogeneic hematopoietic cell transplantation. J Cancer Surviv. 2023;17(3):781–794. doi: 10.1007/s11764-022-01250-8
  • Kamal KM, Covvey JR, Dashputre A, et al. A systematic review of the effect of cancer treatment on work productivity of patients and caregivers. J Manag Care Spec Pharm [Internet]. 2017;23:136–162. doi: 10.18553/jmcp.2017.23.2.136
  • Liu S, Su M, Yao N, et al. Employment changes among Chinese family caregivers of long-term cancer survivors. BMC Public Health. 2020;20(1):1787. doi: 10.1186/s12889-020-09922-9
  • Parker C, Liew D, Ademi Z, et al. Estimating the productivity impact of acute myeloid leukemia in Australia between 2020 and 2029, using a novel work utility measure: the productivity-adjusted life year (PALY). JCO Oncol Pract [Internet]. 2021;17:e1803–e1810. doi: 10.1200/OP.20.00904
  • Hollenbeak CS, Short PF, Moran J. The implications of cancer survivorship for spousal employment. J Cancer Surviv. 2011;5(3):226–234. doi: 10.1007/s11764-011-0175-9
  • Yucel E, Zhang S, Panjabi S. Health-related and economic burden among family caregivers of patients with acute myeloid leukemia or hematological malignancies. Adv Ther. 2021;38(10):5002–5024. doi: 10.1007/s12325-021-01872-x
  • Pössel P, Mitchell AM, Harbison B, et al. Association of cancer caregiver stress and negative attribution style with depressive symptoms and cortisol: a cross-sectional study. Support Care Cancer [Internet]. 2022;30(6):4945–4952. doi: 10.1007/s00520-022-06866-1